Adam Marcus Sorkin
Engineering at 19 St, Cleveland, OH
License number
Louisiana EI.0019457
Issued Date
Jun 13, 2000
Expiration Date
Sep 30, 2005
Category
Civil Engineer
Address
Address
1278 W 19Th St APT 809, Cleveland, OH 44113
Professional information
Adam Sorkin, Pe
Position:
Director, Research and Development at Arteriocyte, Director, Research and Development at Arteriocyte Medical Systems
Location:
Cleveland/Akron, Ohio Area
Industry:
Biotechnology
Work:
Arteriocyte
since Mar 2010
-
Director, Research and Development
Arteriocyte Medical Systems
since Mar 2010
-
Director, Research and Development
Arteriocyte, Inc.
Mar 2009 - Mar 2010
-
Program Manager, R&D
Arteriocyte, Inc.
Oct 2007 - Feb 2009
-
Project Scientist
Case Western Reserve University
2005 - 2007
-
Manager, Center for In Situ Cell and Tissue Imaging
Case Western Reserve University
Oct 2004 - Jan 2007
-
Manager, Experimental Mechanobiology Laboratories
Cleveland Clinic
May 2003 - Oct 2004
-
Laboratory Manager / Research Engineer
Education:
Case Western Reserve University 2007 - 2008
MEM, Biotechnology Entrepreneurship Case Western Reserve University - Weatherhead School of Management 2007 - 2008
MEM, Biotechnology EntrepreneurshipCross functional Management/Engineering/Entrepreneurship program with a focus on biotechnology commercialization Coordinate consulting projects included: Development of a plan to reposition an industrial fuel economy offering for a Fortune 500 specialty chemical company. Guidelines for restructuring corporate governance of a rapidly growing Information Services provider. Assessment of integration of industrial design and engineering facilities for a major commercial design and development house. Tulane University 2000 - 2002
MSE, Biomedical Engineering Tulane University 1996 - 2000
BSE, Biomedical Engineering
MEM, Biotechnology Entrepreneurship Case Western Reserve University - Weatherhead School of Management 2007 - 2008
MEM, Biotechnology EntrepreneurshipCross functional Management/Engineering/Entrepreneurship program with a focus on biotechnology commercialization Coordinate consulting projects included: Development of a plan to reposition an industrial fuel economy offering for a Fortune 500 specialty chemical company. Guidelines for restructuring corporate governance of a rapidly growing Information Services provider. Assessment of integration of industrial design and engineering facilities for a major commercial design and development house. Tulane University 2000 - 2002
MSE, Biomedical Engineering Tulane University 1996 - 2000
BSE, Biomedical Engineering
Skills:
stem cell IP development, molecular imaging, laboratory start-up
Biological Therapeutic Compositions And Methods Thereof
US Patent:
2010018, Jul 22, 2010
Filed:
Jul 7, 2009
Appl. No.:
12/459829
Inventors:
Ramasamy Sakthivel - Solon OH, US
Donald J. Brown - Hopkinton MA, US
Yukang Zhao - Framingham MA, US
Adam Sorkin - Cleveland OH, US
Vincent Pompili - Bexley OH, US
Kevin Mcintosh - Brooklyn Park MN, US
Donald J. Brown - Hopkinton MA, US
Yukang Zhao - Framingham MA, US
Adam Sorkin - Cleveland OH, US
Vincent Pompili - Bexley OH, US
Kevin Mcintosh - Brooklyn Park MN, US
Assignee:
ARTERIOCYTE MEDICAL SYSTEMS - Cleveland OH
International Classification:
A61K 35/12, A61K 35/16
US Classification:
424 937, 424530
Abstract:
Novel uses of Platelet Rich Plasma (PRP) for infection prevention, bone repair and transmyocardial vascularization is disclosed. The present disclosure is directed to methods for preparing concentrated mesenchymal or haematopoietic stem cells, and autologous platelet-rich plasma (PRP) from the blood utilizing the Magallen® System. The stem cells and/or PRP may be combined with secondary biological agents such as antibiotics, fibrinogen and thrombin, and appropriately used in variety of medical conditions, such as, cardiovascular, thoracic, transplantation, head and neck, oral, gastrointestinal, orthopedic, neurosurgical, and plastic surgery.